Cargando…

Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action

Novel adjuvant technologies have a key role in the development of next-generation vaccines, due to their capacity to modulate the duration, strength and quality of the immune response. The AS01 adjuvant is used in the malaria vaccine RTS,S/AS01 and in the licensed herpes-zoster vaccine (Shingrix) wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, Paul R., Alden, Kieran, Coccia, Margherita, Chalon, Aurélie, Collignon, Catherine, Temmerman, Stéphane T., Didierlaurent, Arnaud M., van der Most, Robbert, Timmis, Jon, Andersen, Claus A., Coles, Mark C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751289/ https://www.ncbi.nlm.nih.gov/pubmed/31572370 http://dx.doi.org/10.3389/fimmu.2019.02150

Ejemplares similares

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
por: Coccia, Margherita, et al.
Publicado: (2017)

Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
por: Coccia, Margherita, et al.
Publicado: (2018)

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
por: Loos, Carolin, et al.
Publicado: (2023)

CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01
por: Bosteels, Cedric, et al.
Publicado: (2021)

“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
por: O’Hagan, Derek T., et al.
Publicado: (2021)

Author Correction: “World in motion” – emulsion adjuvants rising to meet the pandemic challenges
por: O’Hagan, Derek T., et al.
Publicado: (2023)

Utilising a simulation platform to understand the effect of domain model assumptions
por: Alden, Kieran, et al.
Publicado: (2014)

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses
por: Coccia, Margherita, et al.
Publicado: (2022)

Pairing experimentation and computational modeling to understand the role of tissue inducer cells in the development of lymphoid organs
por: Alden, Kieran, et al.
Publicado: (2012)

Model-Driven Experimentation: A New Approach to Understand Mechanisms of Tertiary Lymphoid Tissue Formation, Function, and Therapeutic Resolution
por: Butler, James A., et al.
Publicado: (2017)

Simulating CXCR5 Dynamics in Complex Tissue Microenvironments
por: Cosgrove, Jason, et al.
Publicado: (2021)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

Spartan: A Comprehensive Tool for Understanding Uncertainty in Simulations of Biological Systems
por: Alden, Kieran, et al.
Publicado: (2013)

Correction: Spartan: A Comprehensive Tool for Understanding Uncertainty in Simulations of Biological Systems
por: Alden, Kieran, et al.
Publicado: (2013)

Central Role of CD169(+) Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
por: Detienne, Sophie, et al.
Publicado: (2016)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
por: Collignon, Catherine, et al.
Publicado: (2020)

Vaccine Adjuvants: Mode of Action
por: De Gregorio, Ennio, et al.
Publicado: (2013)

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
por: Burny, Wivine, et al.
Publicado: (2017)

Using argument notation to engineer biological simulations with increased confidence
por: Alden, Kieran, et al.
Publicado: (2015)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults
por: van den Berg, Robert A., et al.
Publicado: (2018)

ASPASIA: A toolkit for evaluating the effects of biological interventions on SBML model behaviour
por: Evans, Stephanie, et al.
Publicado: (2017)

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
por: Budroni, Sonia, et al.
Publicado: (2021)

Inulin: A New Adjuvant With Unknown Mode of Action
por: Skwarczynski, Mariusz
Publicado: (2016)

A study of error diversity in robotic swarms for task partitioning in foraging tasks
por: Buchanan, Edgar, et al.
Publicado: (2023)

Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties
por: Givord, Charlotte, et al.
Publicado: (2018)

Erratum: Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action
Publicado: (2019)

Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms
por: Benfield, Aurélie H., et al.
Publicado: (2020)

Mechanisms of Action of Adjuvants
por: Awate, Sunita, et al.
Publicado: (2013)

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine
por: Callegaro, Andrea, et al.
Publicado: (2021)

Building confidence in quantitative systems pharmacology models: An engineer's guide to exploring the rationale in model design and development
por: Timmis, J, et al.
Publicado: (2017)

26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis
por: Callegaro, Andrea, et al.
Publicado: (2021)

Agent‐Based Modeling in Systems Pharmacology
por: Cosgrove, J, et al.
Publicado: (2015)

On the Mode of Action of Strychnia
Publicado: (1868)

On the Mode of Action of Strychnia
por: Spence, Alexander Ingram
Publicado: (1866)

Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
por: Welsby, Iain, et al.
Publicado: (2017)

Toxicity Ranking and Toxic Mode of Action Evaluation of Commonly Used Agricultural Adjuvants on the Basis of Bacterial Gene Expression Profiles
por: Nobels, Ingrid, et al.
Publicado: (2011)

UNDERSTANDING AND ADDRESSING IMMUNOSENESCENCE
por: Van Der Most, Robbert
Publicado: (2019)

Structure and Mode-of-Action of the Two-Peptide (Class-IIb) Bacteriocins
por: Nissen-Meyer, Jon, et al.
Publicado: (2009)

Retinoid metabolism and mode of action.
por: De Luca, L M, et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_bj8h28b0dcamrjli1i7mg82dgq